Cofttek

Cofttek Holding Limited, founded in 2008 and headquartered in Luohe, China, is a high-tech pharmaceutical biochemical enterprise specializing in the research, development, and mass production of advanced pharmaceutical raw materials and intermediates. The company is recognized as a leading global manufacturer of Palmitoylethanolamide (PEA), Alpha GPC, and Nicotinamide Mononucleotide (NMN), serving the pharmaceutical, nutraceutical, and cosmetic industries. Cofttek operates state-of-the-art manufacturing facilities that are ISO9001, ISO14001, and cGMP certified, ensuring high-quality standards for its diverse product portfolio. With a strong focus on R&D, the company also develops small molecule anticancer reagents and kinase inhibitors to support drug discovery and development worldwide. Its products are distributed globally, with a significant presence in North America, Europe, and India.